Thomas Geer
- Biochemistry top 5%
- Hematology top 5%
- Acute Myeloid Leukemia Research 4
- Chronic Myeloid Leukemia Treatments 3
- Platelet Disorders and Treatments 2
- Internal Medicine top 10%
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 7
- Gastroenterology top 10%
-
- Trauma Management and Diagnosis 3
-
- Cancer therapeutics and mechanisms 3
- Kruppel-like factors research 3
-
- Neutropenia and Cancer Infections 3
- Co-authors
- Norman M. RichRobert W. HobsonBurkhard OtrembaMonika RaabN. BrackChristiane SchneiderB. LöfflerP. Harms
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Thomas Geer
19 papers receiving 456 citations
Peers
Comparison fields: 5 of 49
- Biochemistry 123
- Hematology 185
- Internal Medicine 34
- Genetics 94
- Gastroenterology 32
Countries citing papers authored by Thomas Geer
This map shows the geographic impact of Thomas Geer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Geer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Geer more than expected).
Fields of papers citing papers by Thomas Geer
This network shows the impact of papers produced by Thomas Geer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Geer. The network helps show where Thomas Geer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Geer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 6 | |
| 2 | 2023 | 1 | |
| 3 | 2018 | 2 | |
| 4 | 2016 | 6 | |
| 5 | First interim analysis of the German prospective, noninterventional study JAKoMo : First results on the daily clinical routine of ruxolitinib in Myelofibrosis | 2014 | 1 |
| 6 | 2011 | 1 | |
| 7 | 2009 | 47 | |
| 8 | 2006 | 6 | |
| 9 | 2006 | 1 | |
| 10 | 2005 | 44 | |
| 11 | 2005 | 77 | |
| 12 | 2003 | 5 | |
| 13 | 1998 | 200 | |
| 14 | 1998 | 5 | |
| 15 | [Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group]. | 1996 | 2 |
| 16 | 1983 | 3 | |
| 17 | 1980 | 15 | |
| 18 | 1980 | 1 | |
| 19 | 1973 | 68 | |
| 20 | 1961 | 2 |
About Thomas Geer
Thomas Geer is a scholar working on Hematology, Genetics and Gastroenterology, having authored 20 papers that have together received 493 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (4 papers), Trauma Management and Diagnosis (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Cancer therapeutics and mechanisms (3 papers), Neutropenia and Cancer Infections (3 papers), Kruppel-like factors research (3 papers) and Platelet Disorders and Treatments (2 papers). The work is most often cited by research in Biochemistry (123 citations), Hematology (185 citations) and Internal Medicine (34 citations). Thomas Geer has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Norman M. Rich, Robert W. Hobson, Burkhard Otremba, Monika Raab, N. Brack, Christiane Schneider, B. Löffler, P. Harms, Markus H. Frank and Gerhard Ehninger. Their work appears in journals such as Blood, Annals of Hematology, British Journal of Cancer, Journal of Cancer Research and Clinical Oncology and Digestive Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.